252 related articles for article (PubMed ID: 27795412)
21. Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins.
Li A; Baba TW; Sodroski J; Zolla-Pazner S; Gorny MK; Robinson J; Posner MR; Katinger H; Barbas CF; Burton DR; Chou TC; Ruprecht RM
AIDS Res Hum Retroviruses; 1997 May; 13(8):647-56. PubMed ID: 9168233
[TBL] [Abstract][Full Text] [Related]
22. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
[TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env
Zou X; Yuan M; Zhang T; Wei H; Xu S; Jiang N; Zheng N; Wu Z
Theranostics; 2019; 9(19):5657-5671. PubMed ID: 31534509
[No Abstract] [Full Text] [Related]
24. Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.
Sloan DD; Lam CY; Irrinki A; Liu L; Tsai A; Pace CS; Kaur J; Murry JP; Balakrishnan M; Moore PA; Johnson S; Nordstrom JL; Cihlar T; Koenig S
PLoS Pathog; 2015; 11(11):e1005233. PubMed ID: 26539983
[TBL] [Abstract][Full Text] [Related]
25. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.
Blay WM; Kasprzyk T; Misher L; Richardson BA; Haigwood NL
J Virol; 2007 Dec; 81(23):13037-49. PubMed ID: 17855534
[TBL] [Abstract][Full Text] [Related]
26. chFRP5-ZZ-PE38, a large IgG-toxin immunoconjugate outperforms the corresponding smaller FRP5(Fv)-ETA immunotoxin in eradicating ErbB2-expressing tumor xenografts.
Mazor Y; Noy R; Wels WS; Benhar I
Cancer Lett; 2007 Nov; 257(1):124-35. PubMed ID: 17698286
[TBL] [Abstract][Full Text] [Related]
27. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
[TBL] [Abstract][Full Text] [Related]
29. Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1.
Kim YW; Fung MS; Sun NC; Sun CR; Chang NT; Chang TW
J Immunol; 1990 Feb; 144(4):1257-62. PubMed ID: 2303707
[TBL] [Abstract][Full Text] [Related]
30. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
[TBL] [Abstract][Full Text] [Related]
32. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.
Pincus SH; Wehrly K; Chesebro B
J Immunol; 1989 May; 142(9):3070-5. PubMed ID: 2540236
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.
Avalos CR; Price SL; Forsyth ER; Pin JN; Shirk EN; Bullock BT; Queen SE; Li M; Gellerup D; O'Connor SL; Zink MC; Mankowski JL; Gama L; Clements JE
J Virol; 2016 Jun; 90(12):5643-5656. PubMed ID: 27030272
[TBL] [Abstract][Full Text] [Related]
34. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
[TBL] [Abstract][Full Text] [Related]
35. Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents.
Pincus SH; Wehrly K; Chesebro B
Biotechniques; 1991 Mar; 10(3):336-42. PubMed ID: 2064772
[TBL] [Abstract][Full Text] [Related]
36. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.
Bruel T; Guivel-Benhassine F; Lorin V; Lortat-Jacob H; Baleux F; Bourdic K; Noël N; Lambotte O; Mouquet H; Schwartz O
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122982
[TBL] [Abstract][Full Text] [Related]
37. Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.
Marsden MD; Xu J; Hamer D; Zack JA
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1399-404. PubMed ID: 19000022
[TBL] [Abstract][Full Text] [Related]
38. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
39. AZT demonstrates anti-HIV-1 activity in persistently infected cell lines: implications for combination chemotherapy and immunotherapy.
Pincus SH; Wehrly K
J Infect Dis; 1990 Dec; 162(6):1233-8. PubMed ID: 2230256
[TBL] [Abstract][Full Text] [Related]
40. A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent
Chong H; Xue J; Xiong S; Cong Z; Ding X; Zhu Y; Liu Z; Chen T; Feng Y; He L; Guo Y; Wei Q; Zhou Y; Qin C; He Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
